Our business is centrally managed from our global headquarters and commercial organization in Nijmegen, the Netherlands, covering all responsibilities related to the core process. To safeguard coherence between the different sites and efficiency in the core process, strategic management, global portfolio management and global project management for R&D activities are based at HQ.
This is also the case for the majority of staff in our Regulatory Affairs, Intellectual Property and Quality Assurance groups. Our own Clinical Drug Development group encompasses all functions required to conduct bio-equivalence studies, whether these are pivotal clinical trials or pilot studies.
Encompassing business development and account management, our commercial division consists of a group of dedicated professionals, catering to the needs of our customer base of over 200 marketing partners worldwide.
All these activities are supported by a high-quality service organization, including Information Services, Finance & Accounting, Human Resources, Legal Affairs and Corporate Communications. The Nijmegen facility is home to 200 employees from more than 15 nationalities.
In 2017 and 2019, Synthon Nijmegen was named a Best Workplace® according to the Dutch Great Place to Work Institute®. In 2019, Synthon achieved an honorable 9th place in the list of Top 10 Best Multinational Workplaces in the Netherlands.
We develop and use advanced analytical technologies to design efficient manufacturing processes and to deeply characterize and control our products from a chemical, physical and biological perspective. High-quality standards are enforced by bringing science and compliance closely together in our ultramodern manufacturing facilities and quality control laboratories.
Recently initiated activities to expand our production capacity for (high-potent) active pharmaceutical ingredients at our Czech facilities will also meet our future requirements for the manufacturing of new chemical entities.